Kevin Kinsella General Information
Mr. Kevin Kinsella is a Co-Founder of Avalon Ventures. He serves as a Board Member at Eikonizo Therapeutics. He serves as Board Member at Ankasa. He served as Board Member at Avelas Biosciences. He is a Board Member at Jnana Therapeutics. He co-founded HauteDecor and served as its Chairman. He was the Founding Chairman at Landmark Graphics. He has specialized in the formation, financing, and development of more than 100 early-stage companies, including Athena Neurosciences Onyx Pharmaceuticals, Sequana, Vertex Pharmaceuticals, Synaptics, Vocera Communications, Amira Pharmaceuticals, Cardeas Pharma and Juliet Marine Systems. Mr. Kinsella was the founding chairman of Athena Neurosciences, Aurora Biosciences, Landmark Graphics, NeoRx, Onyx Pharmaceuticals, Synaptics, Vertex Pharmaceuticals, X-Ceptor, and Sequana Therapeutics. Prior to founding Avalon, Mr. Kinsella worked for Solar Turbines International (Caterpillar Tractor) where he was in charge of all international joint ventures, barter, and counter-trade. Previously, he was an advisor to the Peruvian government in National Nutrition Planning, ran a technology exchange program between the U.S. and Latin America based in Mexico City and taught algebra at the American High School in Beirut, Lebanon. He was also a guest op-ed columnist for the Boston Herald American. Mr. Kinsella is a graduate of the Massachusetts Institute of Technology ("MIT") with a Bachelor of Science degree in management, with minors in electrical engineering and political science. He holds a Master of Arts degree in international relations from the Johns Hopkins School of Advanced International Studies and conducted post-graduate work in political economy on a Rotary International Fellowship at the University of Stockholm, Sweden. Mr. Kinsella is a member of the Board of Directors of Cardeas Pharma. He also serves as Board Member at Juliet Marine Systems.